Caisse de depot et placement du Quebec
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 898286
Montreal, A8
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,478,352
-$16,258,125 QoQ
Shares Held
13,042
-74.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#432
of 1,745 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caisse de depot et placement du Quebec holds $670,874,502 across 12 Biotechnology names. VRTX ranks #8 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
250,608 | $156,264,112 | |
| 2 | INCY |
Incyte Corp
|
1,370,503 | $155,360,220 | |
| 3 | EXEL |
Exelixis, Inc.
|
2,094,299 | $113,950,808 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,072,439 | $83,939,800 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,236,446 | $70,749,440 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,003,953 | $56,291,644 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
85,748 | $25,812,720 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
13,042 | $6,478,352 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,478,352 | 13,042 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $22,736,477 | 50,917 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $51,577,860 | 113,768 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $87,046,689 | 222,262 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $28,669,099 | 64,396 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $60,528,322 | 124,847 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $57,069,435 | 141,717 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $172,995,342 | 371,969 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $260,451,298 | 555,665 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $357,444,113 | 855,109 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $327,028,072 | 803,726 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $283,764,185 | 816,024 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $306,188,445 | 870,076 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $319,236,170 | 1,013,223 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $262,795,864 | 910,021 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $314,214,598 | 1,085,220 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $360,435,898 | 1,279,094 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $306,537,449 | 1,174,608 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $269,780,356 | 1,228,508 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $271,217,230 | 1,495,216 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $11,528,598 | 57,177 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,869,757 | 8,701 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $419,739 | 1,776 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $817,720 | 3,005 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,046,567 | 3,605 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $866,851 | 3,643 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||